The quality section of the Investigational Medicinal Product Dossier (IMPD) —which deals with the chemistry, manufacturing, and controls (CMC) of a drug— is a very critical factor to have a clinical...
Practical expertise, real-world experience, and hands-on knowledge gained from supporting clinical trials globally for more than 15 years.
We don't just tell you what should be done.
We show you how it's actually done.
What Are the Documents Required for Clinical Trial Applications to Regulatory Authorities in Europe?
Biotech and pharma companies planning clinical trials in Europe will have to submit a clinical trial application (CTA) to the national regulatory authorities of the countries in which the clinical...
QP Declaration: Conducting Clinical Trials in Europe with Drugs Manufactured in Non-EU Countries
Biotech and pharma companies conducting clinical trials in Europe —with a drug product (DP) manufactured in a non-EU country— will need a Qualified Person’s (QP) Declaration when submitting the...
7 Advantages of Conducting a Clinical Trial in Europe
Europe, together with the United States and Asia, is one of the regions in the world where more clinical trials are carried out. Currently in the US database Clinicaltrials.gov, there are 65,572...



